Novavax to Participate in Jefferies London Healthcare Conference
Novavax (NVAX) has announced its participation in the upcoming Jefferies London Healthcare Conference. The company will engage in a fireside chat on November 20, 2024, from 11:00 to 11:25 AM GMT in London. The session will be moderated by Roger Song, MD, CFA, with participation from President and CEO John C. Jacobs and other management team members.
The company will also conduct investor meetings on the same day. A replay of the fireside chat will be accessible for 30 days on Novavax's investor relations website at ir.novavax.com.
Novavax (NVAX) ha annunciato la sua partecipazione al prossimo Jefferies London Healthcare Conference. L'azienda parteciperà a un'intervista informale il 20 novembre 2024, dalle 11:00 alle 11:25 GMT a Londra. La sessione sarà moderata da Roger Song, MD, CFA, con la partecipazione del Presidente e CEO John C. Jacobs e altri membri del team dirigenziale.
L’azienda condurrà anche incontri con investitori lo stesso giorno. Una registrazione dell'intervista informale sarà disponibile per 30 giorni sul sito web delle relazioni con gli investitori di Novavax all'indirizzo ir.novavax.com.
Novavax (NVAX) ha anunciado su participación en la próxima Conferencia de atención médica de Jefferies en Londres. La compañía participará en un chat informal el 20 de noviembre de 2024, de 11:00 a 11:25 AM GMT en Londres. La sesión será moderada por Roger Song, MD, CFA, con la participación del Presidente y CEO John C. Jacobs y otros miembros del equipo directivo.
La compañía también llevará a cabo reuniones con inversores el mismo día. Se podrá acceder a una grabación del chat informal durante 30 días en el sitio web de relaciones con inversores de Novavax en ir.novavax.com.
Novavax (NVAX)는 다가오는 제퍼리스 런던 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 회사는 2024년 11월 20일 오전 11시부터 11시 25분 GMT까지 런던에서 화로 옆 대화에 참여할 예정입니다. 이 세션은 Roger Song, MD, CFA가 진행하며, 회장 겸 CEO John C. Jacobs와 관리 팀의 다른 구성원들이 참여할 것입니다.
회사는 같은 날 투자자 회의도 진행합니다. 화로 옆 대화의 재생은 Novavax의 투자자 관계 웹사이트인 ir.novavax.com에서 30일 동안 제공될 것입니다.
Novavax (NVAX) a annoncé sa participation à la prochaine Conférence de Santé de Jefferies à Londres. L'entreprise participera à une discussion informelle le 20 novembre 2024, de 11h00 à 11h25 GMT à Londres. La session sera modérée par Roger Song, MD, CFA, avec la participation de Président et CEO John C. Jacobs et d'autres membres de l'équipe de direction.
L'entreprise organisera également des réunions avec des investisseurs le même jour. Un replay de la discussion informelle sera accessible pendant 30 jours sur le site web des relations investisseurs de Novavax à l'adresse ir.novavax.com.
Novavax (NVAX) hat seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference angekündigt. Das Unternehmen wird am 20. November 2024 von 11:00 bis 11:25 Uhr GMT in London an einem Kamin-Gespräch teilnehmen. Die Sitzung wird von Roger Song, MD, CFA, moderiert und umfasst die Teilnahme von Präsident und CEO John C. Jacobs sowie anderen Mitgliedern des Managementteams.
Das Unternehmen wird am selben Tag auch Investorengespräche führen. Eine Wiederholung des Kamin-Gesprächs wird für 30 Tage auf der Website der Investor Relations von Novavax unter ir.novavax.com verfügbar sein.
- None.
- None.
Conference Details: | ||||
Fireside Chat | ||||
Date: | Wednesday, November 20, 2024 | |||
Time: | 11:00 – 11:25 a.m. Greenwich Mean Time | |||
Location: | ||||
Moderator: | Roger Song, MD, CFA, Equity Analyst | |||
Novavax participants: | John C. Jacobs, President and Chief Executive Officer and Additional Management Team Members | |||
Investor Meetings | ||||
Date: | Wednesday, November 20, 2024 | |||
Recordings
A replay of the fireside chat will be available on the Events & presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-jefferies-london-healthcare-conference-302303166.html
SOURCE Novavax, Inc.
FAQ
When is Novavax (NVAX) presenting at the Jefferies London Healthcare Conference 2024?
Who will represent Novavax (NVAX) at the Jefferies London Healthcare Conference 2024?
How can I access the replay of Novavax's (NVAX) Jefferies Conference presentation?
What type of session will Novavax (NVAX) participate in at the Jefferies Conference?
